Education
About Us
Working with TipRanks
Follow Us
PROCEPT BioRobotics (PRCT)
NASDAQ:PRCT
PRCT Analyst Ratings
Strong Buy
8 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PRCT Stock 12 Month Forecast
Average Price Target
$80.20
▲(38.42%Upside)
| Highest Price Target$90.00 | Average Price Target$80.20 | Lowest Price Target$71.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$60
Hold
3.56%
Upside
Reiterated
05/31/25
PROCEPT BioRobotics shows promise with strong revenue growth and strategic advancements, especially in Medicare coverage and system sales. However, significant challenges remain in achieving profitability and managing cash flow, compounded by potential tariff impacts. Technical indicators offer a neutral to slightly positive outlook, but the negative valuation metrics weigh heavily on the score.
William Blair
―
Buy
―
Reiterated
06/02/25
Bank of America Securities
―
Buy
―
Reiterated
05/16/25
Jefferies
―
Hold
―
Reiterated
05/02/25
Leerink Partners
$91→$90
Buy
55.33%
Upside
Reiterated
04/28/25
Piper Sandler
$100→$80
Buy
38.07%
Upside
Reiterated
04/28/25
Wells Fargo
$105→$75
Buy
29.44%
Upside
Reiterated
04/27/25
Truist Financial
―
Buy
―
Reiterated
04/25/25
TD Cowen
$85
Buy
46.70%
Upside
Reiterated
04/25/25
Morgan Stanley
$95→$71
Buy
22.54%
Upside
Reiterated
04/24/25
Unknown AnalystTD Securities
Not Ranked
TD Securities
$99→$85
Buy
46.70%
Upside
Reiterated
02/26/25
Lowering PT to $85 from $99.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$60
Hold
3.56%
Upside
Reiterated
05/31/25
PROCEPT BioRobotics shows promise with strong revenue growth and strategic advancements, especially in Medicare coverage and system sales. However, significant challenges remain in achieving profitability and managing cash flow, compounded by potential tariff impacts. Technical indicators offer a neutral to slightly positive outlook, but the negative valuation metrics weigh heavily on the score.
William Blair
―
Buy
―
Reiterated
06/02/25
Bank of America Securities
―
Buy
―
Reiterated
05/16/25
Jefferies
―
Hold
―
Reiterated
05/02/25
Leerink Partners
$91→$90
Buy
55.33%
Upside
Reiterated
04/28/25
Piper Sandler
$100→$80
Buy
38.07%
Upside
Reiterated
04/28/25
Wells Fargo
$105→$75
Buy
29.44%
Upside
Reiterated
04/27/25
Truist Financial
―
Buy
―
Reiterated
04/25/25
TD Cowen
$85
Buy
46.70%
Upside
Reiterated
04/25/25
Morgan Stanley
$95→$71
Buy
22.54%
Upside
Reiterated
04/24/25
Unknown AnalystTD Securities
Not Ranked
TD Securities
$99→$85
Buy
46.70%
Upside
Reiterated
02/26/25
Lowering PT to $85 from $99.
Best Analysts Covering PROCEPT BioRobotics
1 Month
xxx
Success Rate
9/14 ratings generated profit
Average Return
+7.88%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 64.29% of your transactions generating a profit, with an average return of +7.88% per trade.
3 Months
xxx
Success Rate
11/14 ratings generated profit
Average Return
+16.05%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 78.57% of your transactions generating a profit, with an average return of +16.05% per trade.
1 Year
Success Rate
9/12 ratings generated profit
Average Return
+40.02%
reiterated a buy rating 20 days ago
Copying Craig Bijou's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +40.02% per trade.
2 Years
xxx
Success Rate
16/21 ratings generated profit
Average Return
+37.72%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 76.19% of your transactions generating a profit, with an average return of +37.72% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PRCT Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
2
2
7
5
5
Buy
11
11
15
9
8
Hold
4
4
5
4
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
17
17
27
18
16
Each month's total comprises the sum of three months' worth of ratings.
PRCT Financial Forecast
PRCT Stock Forecast FAQ
What is PRCT’s average 12-month price target, according to analysts?
Based on analyst ratings, PROCEPT BioRobotics’s 12-month average price target is 80.20.
What is PRCT’s upside potential, based on the analysts’ average price target?
PROCEPT BioRobotics has 38.42% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PRCT a Buy, Sell or Hold?
PROCEPT BioRobotics has a consensus rating of Strong Buy which is based on 8 buy ratings, 2 hold ratings and 0 sell ratings.
What is PROCEPT BioRobotics’s price target?
The average price target for PROCEPT BioRobotics is 80.20. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $90.00 ,the lowest forecast is $71.00. The average price target represents 38.42% Increase from the current price of $57.94.
The highest analyst price target is $90.00 ,the lowest forecast is $71.00. The average price target represents 38.42% Increase from the current price of $57.94.
What do analysts say about PROCEPT BioRobotics?
PROCEPT BioRobotics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of PRCT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.